Papers
10
Total Citations
193
H-Index
6
About
Olivier Cussenot is a leading French urologist and researcher whose work has fundamentally shaped the surgical and oncological management of urologic cancers, particularly prostate and renal cell carcinoma. His major contributions center on optimizing surgical techniques—from radical prostatectomy to nephroureterectomy—and understanding how patient factors influence cancer outcomes. His landmark 2010 study on distal ureter management during nephroureterectomy (84 citations) established a key oncological principle for upper tract urothelial carcinoma. Cussenot has also been at the forefront of integrating robotics into urologic oncology, as seen in his prospective studies on robot-assisted radical prostatectomy and his exploration of image-guided CyberKnife radiosurgery for prostate cancer. Notably, his research on low circulating testosterone levels as predictors of high-grade prostate tumors (38 citations) has provided critical insights into tumor biology and risk stratification. During the COVID-19 pandemic, he contributed vital safety data on nosocomial transmission in robotic surgery. With a career spanning over a decade of prospective, multi-institutional studies—including the UROCCR network—Cussenot’s work has directly influenced clinical guidelines and surgical practice, making him a pivotal figure in modern urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10